Parag Jitendra Parikh MD
Director, MR-guided Radiation Therapy & Director of GI Radiation Oncology, Henry Ford Cancer Institute
Join to View Full Profile
2800 W. Grand Blvd.Detroit, MI 48202
Phone+1 313-652-2400
Dr. Parikh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2002 - 2006- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2001 - 2002
- WashU MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2018 - 2028
IL State Medical License 2012 - 2020
MO State Medical License 2006 - 2019
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients Start of enrollment: 2005 Aug 12
- Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer Start of enrollment: 2009 Nov 01
- Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma Start of enrollment: 2009 Dec 16
Publications & Presentations
PubMed
- Do Uniform Fasting Instructions Lead to Reproducible Stomach Volumes in Patients Being Treated With Radiation to the Pancreas?Enya V Nguyen, Doris N Rusu, Jennifer L Dolan, Parag J Parikh
Practical Radiation Oncology. 2026-06-15 - Inter-fraction monitoring of brain metastases resection cavities during fractionated stereotactic radiosurgery on the 0.35 T MRI-Linac.Natalia Lutsik, Karen Chin Snyder, Eyub Y Akdemir, Alessandro Valderrama, Gregory A Azzam
Journal of Radiosurgery and SBRT. 2026-01-01 - 1 citations1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trial.Mette van Overeem Felter, Pia Krause Møller, Mirjana Josipovic, Susanne Nørring Bekke, Uffe Bernchou
Radiotherapy and Oncology. 2025-04-01
Press Mentions
Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic CancerNovember 21st, 2022- Looking Ahead to ASTRO: Keynotes, Awards and Scientific Session UpdatesOctober 6th, 2022
- Henry Ford Health 1st in World to Offer Newest MR-Guided Radiation TherapyJune 3rd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
